Annual Revenue
$219.79 M
+$82.75 M+60.38%
31 December 2023
Summary:
Castle Biosciences annual revenue is currently $219.79 million, with the most recent change of +$82.75 million (+60.38%) on 31 December 2023. During the last 3 years, it has risen by +$157.14 million (+250.82%). CSTL annual revenue is now at all-time high.CSTL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$85.78 M
-$1.22 M-1.40%
30 September 2024
Summary:
Castle Biosciences quarterly revenue is currently $85.78 million, with the most recent change of -$1.22 million (-1.40%) on 30 September 2024. Over the past year, it has increased by +$24.29 million (+39.50%). CSTL quarterly revenue is now -1.40% below its all-time high of $87.00 million, reached on 30 June 2024.CSTL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$311.88 M
+$24.29 M+8.45%
30 September 2024
Summary:
Castle Biosciences TTM revenue is currently $311.88 million, with the most recent change of +$24.29 million (+8.45%) on 30 September 2024. Over the past year, it has increased by +$119.87 million (+62.43%). CSTL TTM revenue is now at all-time high.CSTL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.4% | +39.5% | +62.4% |
| 3 y3 years | +250.8% | +265.4% | +261.2% |
| 5 y5 years | +864.6% | +480.6% | +583.0% |
CSTL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +250.8% | -1.4% | +265.4% | at high | +261.2% |
| 5 y | 5 years | at high | +864.6% | -1.4% | +574.6% | at high | +583.0% |
| alltime | all time | at high | +1498.0% | -1.4% | +2244.7% | at high | +8424.5% |
Castle Biosciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $85.78 M(-1.4%) | $311.88 M(+8.4%) |
| June 2024 | - | $87.00 M(+19.2%) | $287.59 M(+14.7%) |
| Mar 2024 | - | $72.97 M(+10.4%) | $250.72 M(+14.1%) |
| Dec 2023 | $219.79 M(+60.4%) | $66.12 M(+7.5%) | $219.79 M(+14.5%) |
| Sept 2023 | - | $61.49 M(+22.6%) | $192.01 M(+14.6%) |
| June 2023 | - | $50.14 M(+19.3%) | $167.52 M(+10.1%) |
| Mar 2023 | - | $42.04 M(+9.6%) | $152.22 M(+11.1%) |
| Dec 2022 | $137.04 M(+45.7%) | $38.34 M(+3.6%) | $137.04 M(+10.7%) |
| Sept 2022 | - | $37.01 M(+6.2%) | $123.74 M(+12.3%) |
| June 2022 | - | $34.84 M(+29.7%) | $110.20 M(+12.3%) |
| Mar 2022 | - | $26.85 M(+7.2%) | $98.12 M(+4.3%) |
| Dec 2021 | $94.08 M | $25.04 M(+6.7%) | $94.08 M(+9.0%) |
| Sept 2021 | - | $23.48 M(+3.2%) | $86.34 M(+10.6%) |
| June 2021 | - | $22.76 M(-0.2%) | $78.09 M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $22.81 M(+31.9%) | $68.04 M(+8.6%) |
| Dec 2020 | $62.65 M(+20.8%) | $17.30 M(+13.7%) | $62.65 M(-0.5%) |
| Sept 2020 | - | $15.22 M(+19.7%) | $62.98 M(+0.7%) |
| June 2020 | - | $12.71 M(-27.0%) | $62.54 M(+3.3%) |
| Mar 2020 | - | $17.42 M(-1.2%) | $60.57 M(+16.8%) |
| Dec 2019 | $51.87 M(+127.6%) | $17.64 M(+19.4%) | $51.87 M(+13.6%) |
| Sept 2019 | - | $14.77 M(+37.6%) | $45.67 M(+32.0%) |
| June 2019 | - | $10.74 M(+23.2%) | $34.60 M(+24.3%) |
| Mar 2019 | - | $8.72 M(-23.8%) | $27.84 M(+22.2%) |
| Dec 2018 | $22.79 M(+65.7%) | $11.44 M(+208.1%) | $22.79 M(+100.8%) |
| Sept 2018 | - | $3.71 M(-6.7%) | $11.35 M(+48.6%) |
| June 2018 | - | $3.98 M(+8.8%) | $7.64 M(+108.8%) |
| Mar 2018 | - | $3.66 M | $3.66 M |
| Dec 2017 | $13.75 M | - | - |
FAQ
- What is Castle Biosciences annual revenue?
- What is the all time high annual revenue for Castle Biosciences?
- What is Castle Biosciences annual revenue year-on-year change?
- What is Castle Biosciences quarterly revenue?
- What is the all time high quarterly revenue for Castle Biosciences?
- What is Castle Biosciences quarterly revenue year-on-year change?
- What is Castle Biosciences TTM revenue?
- What is the all time high TTM revenue for Castle Biosciences?
- What is Castle Biosciences TTM revenue year-on-year change?
What is Castle Biosciences annual revenue?
The current annual revenue of CSTL is $219.79 M
What is the all time high annual revenue for Castle Biosciences?
Castle Biosciences all-time high annual revenue is $219.79 M
What is Castle Biosciences annual revenue year-on-year change?
Over the past year, CSTL annual revenue has changed by +$82.75 M (+60.38%)
What is Castle Biosciences quarterly revenue?
The current quarterly revenue of CSTL is $85.78 M
What is the all time high quarterly revenue for Castle Biosciences?
Castle Biosciences all-time high quarterly revenue is $87.00 M
What is Castle Biosciences quarterly revenue year-on-year change?
Over the past year, CSTL quarterly revenue has changed by +$24.29 M (+39.50%)
What is Castle Biosciences TTM revenue?
The current TTM revenue of CSTL is $311.88 M
What is the all time high TTM revenue for Castle Biosciences?
Castle Biosciences all-time high TTM revenue is $311.88 M
What is Castle Biosciences TTM revenue year-on-year change?
Over the past year, CSTL TTM revenue has changed by +$119.87 M (+62.43%)